These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6548287)

  • 1. Retinopathy of prematurity in extremely low birthweight infants.
    Keith CG; Kitchen WH
    Med J Aust; 1984 Aug; 141(4):225-7. PubMed ID: 6548287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E and retrolental fibroplasia: prevention of serious ocular sequelae.
    Finer NN; Peters KL; Schindler RF; Grant GD
    Ciba Found Symp; 1983; 101():147-64. PubMed ID: 6360586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrolental fibroplasia: a study of the incidence and aetiological factors, 1977-1979.
    Keith CG; Smith ST; Lansdell BJ
    Med J Aust; 1981 Nov; 2(11):589-92. PubMed ID: 6895927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The premature infant, vitamin E deficiency and retrolental fibroplasia.
    Johnson L; Schaffer D; Boggs TR
    Am J Clin Nutr; 1974 Oct; 27(10):1158-73. PubMed ID: 4608928
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship of blood transfusions to retrolental fibroplasia.
    Mittelman D; Cronin C
    Ann Ophthalmol; 1983 Apr; 15(4):376-8. PubMed ID: 6689255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E and retinopathy of prematurity. Follow-up at one year.
    Schaffer DB; Johnson L; Quinn GE; Weston M; Bowen FW
    Ophthalmology; 1985 Aug; 92(8):1005-11. PubMed ID: 3900846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current therapy of retrolental fibroplasia. Retinopathy of prematurity.
    Patz A
    Ophthalmology; 1983 May; 90(5):425-7. PubMed ID: 6348634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors of retinopathy of prematurity in extremely low birth weight infants by strictly controlling oxygen inhalation after birth].
    Mao JB; Yu XT; Shen LJ; Wu MY; Lyu Z; Lao JM; Li HX; Wu HF; Chen YQ
    Zhonghua Yan Ke Za Zhi; 2019 Apr; 55(4):280-288. PubMed ID: 30982290
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk factors in retrolental fibroplasia.
    Gunn TR; Easdown J; Outerbridge EW; Aranda JV
    Pediatrics; 1980 Jun; 65(6):1096-100. PubMed ID: 6892851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of retrolental fibroplasia.
    Patz A
    Metab Pediatr Syst Ophthalmol; 1982; 6(3-4):185-7. PubMed ID: 6897868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence and evolution of retinopathy of prematurity. A six year experience in a neonatal intensive care unit].
    Didato MA; Gioeli RA; Scimemi M; Cascio G
    Minerva Pediatr; 1992 Nov; 44(11):519-23. PubMed ID: 1297918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinopathy of prematurity: causation.
    Mccolm JR; Fleck BW
    Semin Neonatol; 2001 Dec; 6(6):453-60. PubMed ID: 12014886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrolental fibroplasia--controlled study of 4 years' experience in a neonatal intensive care unit.
    Yu VY; Hookham DM; Nave JR
    Arch Dis Child; 1982 Apr; 57(4):247-52. PubMed ID: 6896273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe retinopathy of prematurity in infants with birth weights less than 1250 grams: incidence and outcome of treatment with pharmacologic serum levels of vitamin E in addition to cryotherapy from 1985 to 1991.
    Johnson L; Quinn GE; Abbasi S; Gerdes J; Bowen FW; Bhutani V
    J Pediatr; 1995 Oct; 127(4):632-9. PubMed ID: 7562291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinopathy of prematurity: incidence and risk factors.
    Shohat M; Reisner SH; Krikler R; Nissenkorn I; Yassur Y; Ben-Sira I
    Pediatrics; 1983 Aug; 72(2):159-63. PubMed ID: 6408596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial.
    Johnson L; Quinn GE; Abbasi S; Otis C; Goldstein D; Sacks L; Porat R; Fong E; Delivoria-Papadopoulos M; Peckham G
    J Pediatr; 1989 May; 114(5):827-38. PubMed ID: 2654350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood transfusion: a possible risk factor in retrolental fibroplasia.
    Clark C; Gibbs JA; Maniello R; Outerbridge EW; Aranda JV
    Acta Paediatr Scand; 1981 Jul; 70(4):537-9. PubMed ID: 6895573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of retrolental fibroplasia in low birth weight infants receiving oxygen therapy].
    Horváth M; Vastagh O; Rubecz I; Heim T
    Orv Hetil; 1981 Aug; 122(32):1943-6. PubMed ID: 7029395
    [No Abstract]   [Full Text] [Related]  

  • 19. Retrolental fibroplasia and blood transfusion in very low-birth-weight infants.
    Sacks LM; Schaffer DB; Anday EK; Peckham GJ; Delivoria-Papadopoulos M
    Pediatrics; 1981 Dec; 68(6):770-4. PubMed ID: 6895663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular morbidity in infants of very low birth weight.
    Keith CG; Kitchen WH
    Br J Ophthalmol; 1983 May; 67(5):302-5. PubMed ID: 6687689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.